Moderna Reports Positive Phase 3 Data For Flu And COVID Combination Vaccine

Moderna, Inc. (MRNA) announced Monday that its Phase 3 trial of mRNA-1083, an investigational combination vaccine against influenza and COVID-19, has met its primary endpoints. Moderna is the only company with a positive Phase 3 flu and COVID combination vaccine. mRNA-1083 elicited higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID...

Read More

BioSig Technologies Announces Appointment Of Ferdinand Groenewald As Interim CFO

Medical technology company BioSig Technologies, Inc. (BSGM) announced Monday the appointment of Ferdinand Groenewald to the position of interim Chief Financial Officer. Groenewald is a certified public accountant with significant experience in finance and accounting. He currently serves as Vice President, Finance at Alaunos Therapeutics, Inc. Previously, he served as an Independent Outside Director at...

Read More

Canadian Market Slightly Higher In Cautious Trade

Energy, technology and materials stocks are finding some support in the Canadian market, where the mood remains quite cautious Monday morning as investors look ahead to crucial U.S. consumer price inflation data and the Federal Reserve\'s monetary policy announcement this week. The Fed is unlikely to make any change in interest rate, but the bank\'s...

Read More

Japan Q1 GDP Unrevised At -0.5% On Quarter

Japan\'s gross domestic product contracted a seasonally adjusted 0.5 percent on quarter in the first quarter of 2024, the Cabinet Office said on Monday - matching forecasts and unrevised from last month\'s advance estimate. GDP was up 0.1 percent on quarter in the fourth quarter of 2023. On an annualized basis, GDP was revised up...

Read More